Clinical Trial Update: ATAC - Endometrial Sub-Protocol [Phase 3]

View source ↗

Summary

Phase 3 trial update for the ATAC study’s endometrial safety sub-protocol in breast cancer has completed as part of the overall ATAC program.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Anastrozole (Anastrozole)
• Tamoxifen (tamoxifen)

Snippet

Sponsor: AstraZeneca | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED